{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:53:58Z","timestamp":1761710038349,"version":"build-2065373602"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>\n                    The incidence and risk factors for propofol-associated hypertriglyceridemia (HTG) in patients receiving extracorporeal membrane oxygenation (ECMO) have not been evaluated. The purpose of this study was to determine the incidence and risk factors for propofol-associated HTG in patients with acute respiratory distress syndrome (ARDS) on ECMO. This retrospective, cohort study included 167 adults admitted to a medical intensive care unit (ICU) from July 1, 2013 to September 1, 2021, who received 24 hours of concurrent propofol and ECMO therapy. The primary outcome was the incidence of propofol-associated HTG. Secondary outcomes included HTG risk factors, time to development and resolution of HTG, and incidence of pancreatitis. HTG occurred in 58 (34.7%) patients. Patients with HTG had longer durations of ECMO (19\n                    <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                    13 days,\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    &lt; 0.001), longer ICU length of stay (26.5\n                    <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                    23 days,\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    = 0.002), and higher in-hospital mortality (51.7\n                    <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                    34.9%,\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    = 0.047). Baseline sequential organ failure assessment score was associated with an increased risk of developing HTG (hazard ratio [HR] = 1.19, 95% confidence interval [CI] = 1.09\u20131.30;\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    &lt; 0.001). Propofol-associated HTG occurred in one-third of patients receiving ECMO for ARDS. Higher baseline illness severity and ECMO duration were associated with an increased risk of propofol-associated HTG.\n                  <\/jats:p>","DOI":"10.1097\/mat.0000000000001978","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T14:00:50Z","timestamp":1683900050000},"page":"856-862","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Propofol-Associated Hypertriglyceridemia in Adults With Acute Respiratory Distress Syndrome on Extracorporeal Membrane Oxygenation"],"prefix":"10.1097","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-013X","authenticated-orcid":false,"given":"Sara","family":"Stallworth","sequence":"first","affiliation":[{"name":"Duke University Hospital, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey","family":"Ohman","sequence":"additional","affiliation":[{"name":"Duke University Hospital, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Schultheis","sequence":"additional","affiliation":[{"name":"Duke University Hospital, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Parish","sequence":"additional","affiliation":[{"name":"Duke University Hospital, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaattin","family":"Erkanli","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heewon","family":"Kim","sequence":"additional","affiliation":[{"name":"Duke University Hospital, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig R.","family":"Rackley","sequence":"additional","affiliation":[{"name":"Duke University Hospital, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"R1-20251022","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries.","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"key":"R2-20251022","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0391398819833376","article-title":"Propofol-based sedation does not negatively influence oxygenator running time compared to midazolam in patients with extracorporeal membrane oxygenation.","volume":"42","author":"Lamm","year":"2019","journal-title":"Int J Artif Organs"},{"key":"R3-20251022","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1007\/s00134-020-06307-9","article-title":"Analgesia and sedation in patients with ARDS.","volume":"46","author":"Chanques","year":"2020","journal-title":"Intensive Care Med"},{"key":"R4-20251022","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome.","volume":"377","author":"Thompson","year":"2017","journal-title":"N Engl J Med"},{"key":"R5-20251022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/10600280211010751","article-title":"Approach to sedation and analgesia in COVID-19 patients on venovenous extracorporeal membrane oxygenation.","volume":"56","author":"Dreucean","year":"2022","journal-title":"Ann Pharmacother"},{"key":"R6-20251022","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/1060028019877806","article-title":"Sedation requirements in patients on venovenous or venoarterial extracorporeal membrane oxygenation.","volume":"54","author":"Patel","year":"2020","journal-title":"Ann Pharmacother"},{"key":"R7-20251022","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU.","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"key":"R8-20251022","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcrc.2019.05.014","article-title":"Current practice and perceptions regarding pain, agitation and delirium management in patients receiving venovenous extracorporeal membrane oxygenation.","volume":"53","author":"Dzierba","year":"2019","journal-title":"J Crit Care"},{"key":"R9-20251022","first-page":"e0330","article-title":"Evaluation of hypertriglyceridemia in critically ill patients with coronavirus disease 2019 receiving propofol.","volume":"3","author":"Kovacevic","year":"2021","journal-title":"Crit Care Explor"},{"key":"R10-20251022","first-page":"e0303","article-title":"Propofol-associated hypertriglyceridemia in coronavirus disease 2019 versus noncoronavirus disease 2019 acute respiratory distress syndrome.","volume":"2","author":"Kenes","year":"2020","journal-title":"Crit Care Explor"},{"key":"R11-20251022","first-page":"e0282","article-title":"The incidence of propofol-induced hypertriglyceridemia and identification of associated risk factors.","volume":"2","author":"Corrado","year":"2020","journal-title":"Crit Care Explor"},{"key":"R12-20251022","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/gastro\/goy038","article-title":"Acute pancreatitis associated with intravenous administration of propofol: Evaluation of causality in a systematic review of the literature.","volume":"7","author":"Haffar","year":"2019","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"R13-20251022","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/cc8145","article-title":"Incidence of propofol-related infusion syndrome in critically ill adults: A prospective, multicenter study.","volume":"13","author":"Roberts","year":"2009","journal-title":"Crit Care"},{"issue":"Suppl 5","key":"R14-20251022","doi-asserted-by":"crossref","first-page":"S629","DOI":"10.21037\/jtd.2017.09.154","article-title":"Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.","volume":"10","author":"Cheng","year":"2018","journal-title":"J Thorac Dis"},{"key":"R15-20251022","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/MAT.0000000000000461","article-title":"Safety of propofol for oxygenator exchange in extracorporeal membrane oxygenation.","volume":"63","author":"Hohlfelder","year":"2017","journal-title":"ASAIO J"},{"key":"R16-20251022","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/2050640618755002","article-title":"Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management.","volume":"6","author":"de Pretis","year":"2018","journal-title":"United Eur Gastroenterol J"},{"key":"R17-20251022","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1592\/phco.2005.25.10.1348","article-title":"Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: An analysis of frequency and risk factors.","volume":"25","author":"Devlin","year":"2005","journal-title":"Pharmacotherapy"},{"key":"R18-20251022","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s00134-012-2688-8","article-title":"Hypertriglyceridemia: A potential side effect of propofol sedation in critical illness.","volume":"38","author":"Devaud","year":"2012","journal-title":"Intensive Care Med"},{"key":"R19-20251022","first-page":"2526","article-title":"Acute respiratory distress syndrome: The Berlin definition.","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"R20-20251022","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"R21-20251022","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.mcg.0000436438.60145.5a","article-title":"Issues in hypertriglyceridemic pancreatitis: An update.","volume":"48","author":"Scherer","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"R22-20251022","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/ajg.2013.218","article-title":"American College of Gastroenterology guideline: Management of acute pancreatitis.","volume":"108","author":"Tenner","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R23-20251022","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks.","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"R24-20251022","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data.","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"key":"R25-20251022","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1513\/AnnalsATS.202205-403OC","article-title":"Triglyceride concentrations and their relationship to sedation choice and outcomes in mechanically ventilated patients receiving propofol.","volume":"20","author":"Pancholi","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"R26-20251022","first-page":"451","article-title":"Hypertriglyceridemia independent propofol-induced pancreatitis.","volume":"13","author":"Muniraj","year":"2012","journal-title":"Jop"},{"key":"R27-20251022","first-page":"e0310","article-title":"Volatile sedation for acute respiratory distress syndrome patients on venovenous extracorporeal membrane oxygenation and ultraprotective ventilation.","volume":"3","author":"Grasselli","year":"2021","journal-title":"Crit Care Explor"},{"key":"R28-20251022","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1053\/j.gastro.2018.01.032","article-title":"American gastroenterological association institute guideline on initial management of acute pancreatitis.","volume":"154","author":"Crockett","year":"2018","journal-title":"Gastroenterology"},{"key":"R29-20251022","first-page":"e0584","article-title":"A daily, respiratory therapist assessment of readiness to liberate from venovenous extracorporeal membrane oxygenation in patients with acute respiratory distress syndrome.","volume":"3","author":"Pratt","year":"2021","journal-title":"Crit Care Explor"}],"container-title":["ASAIO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MAT.0000000000001978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:00:38Z","timestamp":1761174038000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MAT.0000000000001978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mat.0000000000001978","relation":{},"ISSN":["1058-2916"],"issn-type":[{"type":"print","value":"1058-2916"}],"subject":[],"published":{"date-parts":[[2023,5,12]]}}}